Old Web
English
Sign In
Acemap
>
authorDetail
>
Y. Zhang
Y. Zhang
Pfizer
Cancer research
Medicine
Biology
Lupus erythematosus
Interim
4
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I, randomized, double-blind study to assess the safety, tolerability, and efficacy of the topical RORC2 inverse agonist PF-06763809 in participants with mild-to-moderate plaque psoriasis.
2020
Clinical and Experimental Dermatology
Gabriel Berstein
Y. Zhang
Z. Berger
Elizabeth Kieras
G. Li
A. Samuel
T. Yeoh
H. Dowty
K. Beaumont
Walter Wigger-Alberti
Y. von Mackensen
U. Kroencke
R. Hamscho
Sandra Garcet
James G. Krueger
Christopher Banfield
B. Oemar
Show All
Source
Cite
Save
Citations (5)
OP0063 Impact of baseline interferon pathway activation on widespread gene expression changes with disease flare in lupus patients: Interim report from the bold (biomarkers of lupus disease) study
2013
Annals of the Rheumatic Diseases
A. Seyhan
Margot OToole
Y. Zhang
Frederick W. Immermann
Andrew A. Hill
Padmalatha S. Reddy
J. Masferrer
T. Zhou
William M. Mounts
Maryann Whitley
T. Walker
S. Kamp
Judith A. James
S. Sridharan
Joan T. Merrill
Marek Honczarenko
Show All
Source
Cite
Save
Citations (1)
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
2012
Leukemia
Todd Waldron
M De Dominici
Angela Rachele Soliera
Alessandra Audia
Ilaria Iacobucci
Annalisa Lonetti
G. Martinelli
Y. Zhang
Robert V. Martinez
Terry Hyslop
Tp Bender
Bruno Calabretta
Show All
Source
Cite
Save
Citations (37)
Endogenous IFN? Directly Regulates Neural Precursors in the Non-inflammatory Brain
2008
Li Li
Tara L. Walker
Y. Zhang
Perry F. Bartlett
Show All
Source
Cite
Save
Citations (0)
1